- POSITIVE
Annual Revenue Vaidya Sane Ayurved Mar-2026 Annual Revenue is Rs 102 Cr which is growth of 14.5% YoY.
- POSITIVE
Annual Net Profit Vaidya Sane Ayurved Mar-2026 Annual Net Profit is Rs 5 Cr which is growth of 0.8% YoY.
Madhavbaug is a medical service institution engaged in the treatment of chronic ailments like cardiac disease, diabetes, hypertension, and obesity by combining modern technology with traditional Ayurveda practices.
| Bidding Dates |
|---|
| 10 Feb 2022 - 15 Feb 2022 |
| Subscription |
|---|
| 2.82x Oversubscribed |
| Minimum Investment | Minimum Lot | Maximum Lot | Lot Size | Number of Shares | Issue Price | Post Issue Promoter Holding % | Issue Size | IPO Document |
|---|---|---|---|---|---|---|---|---|
| ₹116,800 | 1 | 1 | 1600 | 2.8 M | ₹73 | 73.64 % | ₹202.3 M | RHP DOC |
Vaidya Sane Ayurved IPO SUBSCRIPTION STATUS
15 Feb '22Total2.82x
Retail Individual Investor2.98x
HNI (NII) Investors2.66x
Qualified Institutional Buyers-
Vaidya Sane Ayurved IPO overall subscription rate was 2.82 times the total available shares
Vaidya Sane Ayurved IPO retail subscription rate was 2.98 times in the retail segment
Vaidya Sane Ayurved IPO non-institutional investor subscription rate was 2.66 times in the non-institutional investor category
| Day | Retail Individual Investor | HNI (NII) Investors | Qualified Institutional Buyers |
|---|---|---|---|
| Category Reservation | 50% | 50% | - |
15 Feb 2022 (Day 4) | 2.98x | 2.66x | - |
10 Feb 2022 (Day 1) | 0.59x | 0.4x | - |
11 Feb 2022 (Day 2) | 1.01x | 0.95x | - |
14 Feb 2022 (Day 3) | 1.51x | 1.62x | - |
Vaidya Sane Ayurved FINANCIALS
| Period | Net Profit (Rs in millions) | Revenue from operations (Rs in millions) | Cash Flow from operations (Rs in millions) | Free Cash flow (Rs in millions) |
| 6MFY21 | 13.5 | 315.6 | 6.5 | -1.2 |
| FY21 | 15.5 | 522.7 | 57.8 | 51.0 |
| FY20 | -5.6 | 752.3 | 77.2 | 38.7 |
| FY19 | 5.0 | 625.0 | 15.8 | -73.9 |
Vaidya Sane Ayurved IPO SUBSCRIPTION STATUS DETAILS
Vaidya Sane Ayurved had 2.8 M shares on offer
Vaidya Sane Ayurved IPO offer price was ₹73
Vaidya Sane Ayurved IPO minimum Investment was ₹116800
Vaidya Sane Ayurved IPO issue size was ₹ 202.3 M
Vaidya Sane Ayurved had a minimum lot size of 1600 Shares per application
Vaidya Sane Ayurved NUMBER OF SHARES ON OFFER
Total2.8 M
Fresh Issue2.8 M
Offer for Sale0
Post Issue Promoter Holding %73.64 %
Vaidya Sane Ayurved IPO IMPORTANT DATES
| Issue Open Date | 10 Feb 2022 |
| Issue close Date | 15 Feb 2022 |
| Allotment Date | 18 Feb 2022 |
| Refund Date | 21 Feb 2022 |
| Demat Account Credit Date | 22 Feb 2022 |
| Listing Date | 23 Feb 2022 |
| Listing on Exchange(s) | NSE |
| Vaidya Sane Ayurved Allotment Status | Exchange |
Vaidya Sane Ayurved IPO subscription opened on 10 Feb 2022, and closed on 15 Feb 2022
IPO allotment for Vaidya Sane Ayurved was finalized on Friday, 18 Feb 2022
IPO listing for Vaidya Sane Ayurved was on NSE on Wednesday, 23 Feb 2022
Vaidya Sane Ayurved IPO LISTING GAINS
| Issue Price (adjusted) | 73.0 |
| Listing Open Price | 102.0 |
| Listing Close Price | 105.4 |
| Listing Gain% | 39.7% |
| Current Gain% | 86.3% |
Vaidya Sane Ayurved Peer
| Stock | Stock Price | Market Cap (Rs crore) | PE TTM | PEG TTM | PS TTM | ROE% | ROA% | Annual Revenue (Rs crore) | Annual Revenue Growth % | Annual Net Profit (Rs crore) | Annual Net Profit Growth % | EPS TTM | EPS TTM Growth % |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Vaidya Sane Ayurved Laboratories Ltd. | 136 | 143 | 15.9 | 0.6 | 1.3 | 12.5 | 8.6 | 109.3 | 19.2 | 9 | 25.9 | 8.5 | 25.9 |
| Apollo Hospitals Enterprise Ltd. | 8448 | 121469.3 | 58.1 | 1.8 | 4.6 | 20.5 | 8.7 | 25420.1 | 15.6 | 1941.7 | 34.3 | 145.3 | 32.8 |
| Manipal Health Enterprises Ltd. | 669.2 | 88018.5 | 10.6 | 3.6 | 10520.5 | 25.8 | 892.3 | -16.2 | |||||
| Max Healthcare Institute Ltd. | 860 | 83704.7 | 60.6 | 35 | 9.2 | 13.4 | 8.4 | 8536.1 | 18.8 | 1442.4 | 34.1 | 14.2 | 1.7 |
| Aster DM Quality Care Ltd. | 681.2 | 59374 | 186.3 | 1162.3 | 12.2 | 8.5 | 4.8 | 4768.8 | 11.2 | 388.1 | -92.8 | 3.7 | 0.2 |
| Fortis Healthcare Ltd. | 768.2 | 57992.1 | 55.3 | 2.7 | 6.1 | 10.5 | 6.5 | 9178.5 | 16.9 | 1041.8 | 34.6 | 13.9 | 20.7 |
Revenue Mix
Annual
Balance Sheet
Ratios
Cash Flow
Vaidya Sane Ayurved annual results: revenue, profit, P&L, and margins as of Mar 2026 – 11 year history
Nested row level
Base Level
Reporting Type
Standalone
Cell Data
Actual
Table Settings
YoY & New to Old
CAGR Columns
Select...
Nested row level
Base Level
Export
| Indicator | Graph | CAGR 3 Yrs | CAGR 5 Yrs | Mar '26 | Mar '25 | Mar '24 | Mar '23 | Mar '22 | Mar '21 | Mar '20 | Mar '19 | Mar '18 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
0.5% | 14.2% | 101.8 | 88.9 | 98.9 | 100.4 | 75.1 | 52.3 | 75.3 | 62.6 | 37.7 | ||
Operating Exp. Ann. | -0.5% | 13.4% | 89.3 | 77 | 94.2 | 90.7 | 67.8 | 47.7 | 71.9 | 59.1 | 35.3 | |
Operating Profit Ann. | 7.5% | 17.5% | 10.3 | 10.1 | 3.2 | 8.3 | 6.9 | 4.6 | 3.3 | 3.4 | 2.4 | |
OPM Ann. % | 6.9% | 2.8% | 10.14% | 11.40% | 3.21% | 8.30% | 9.21% | 8.84% | 4.43% | 5.50% | 6.32% | |
0.8% | 13.5% | 95.7 | 80.8 | 97.4 | 93.5 | 70.3 | 50.7 | 75.1 | 61.2 | 36.3 | ||
EBITDA Ann. | 8.8% | 22.1% | 12.5 | 11.9 | 4.7 | 9.7 | 7.3 | 4.6 | 3.4 | 3.5 | 2.4 | |
EBITDA Ann. margin % | 8.4% | 6.8% | 12.29% | 13.39% | 4.78% | 9.66% | 9.66% | 8.85% | 4.52% | 5.62% | 6.46% | |
Interest Ann. | 58.7% | 5.9% | 0.8 | 0.1 | 0.3 | 0.2 | 0.2 | 0.6 | 0.9 | 0.6 | 0.1 | |
Depr. | 29.1% | 17.5% | 5.6 | 3.7 | 3 | 2.6 | 2.3 | 2.5 | 2.2 | 1.6 | 0.9 | |
PBT Ann. | -4% | 30.7% | 6.1 | 6.9 | 1.5 | 6.9 | 4.8 | 1.6 | 0.2 | 1.4 | 1.4 | |
Tax Ann. | -11% | 64.4% | 1.2 | 2 | 0.4 | 1.7 | 1.3 | 0.1 | 0.1 | 0.4 | 0.4 | |
-2% | 25.1% | 4.9 | 4.9 | 1 | 5.2 | 3.5 | 1.6 | 0.1 | 1 | 1.1 | ||
Net Profit Ann. | -2% | 65.1% | 4.9 | 4.9 | 1 | 5.2 | 3.5 | 0.4 | 0.1 | 1 | 1.1 | |
NPM Ann. % | -1.9% | 46.2% | 4.95% | 5.62% | 1.07% | 5.24% | 4.64% | 0.74% | 0.16% | 1.55% | 2.83% | |
EPS Adj. latest Ann. | -1.4% | 63.7% | 4.7 | 4.7 | 1 | 4.9 | 3.3 | 0.4 | 0.1 | 0.9 | 1 |
*All financials are in INR Cr and price data in INR
Add metric to table
Search...
Total Rev. Ann.
1Y CHG
14.5%
2Y CAGR
1.5%
3Y CAGR
0.5%
5Y CAGR
14.2%
7Y CAGR
7.2%
Total Revenue Annual growth is higher than historical averages.
Net Profit Ann.
2Y CAGR
121.4%
3Y CAGR
-2%
5Y CAGR
65.1%
7Y CAGR
25.5%
Net Profit Annual growth is stable compared to historical averages.
Operating Exp. Ann.
1Y CHG
16%
2Y CAGR
-2.6%
3Y CAGR
-0.5%
5Y CAGR
13.4%
7Y CAGR
6.1%
Operating Expenses Annual Cr growth is higher than historical averages.
Vaidya Sane Ayurved INFORMATION ON IPO ISSUE
About Vaidya Sane Ayurved
Madhavbaug is a medical service institution engaged in the treatment of chronic ailments like cardiac disease, diabetes, hypertension, and obesity by combining modern technology with traditional Ayurveda practices.
Object of the Issue
- Funding branding and advertising expenses
- General corporate purpose
Vaidya Sane Ayurved - PROMOTERS
| Name |
|---|
| Rohit Madhav Sane |
Vaidya Sane Ayurved Lead Manager
First Overseas Capital Limited
satish@focl.in
Vaidya Sane Ayurved Registrar to the issue
Bigshare Services Private Limited
ipo@bigshareonline.com
Vaidya Sane Ayurved Strengths
Combination of modern healing methods and ancient natural practices
The company's diagnostic methods are backed by the latest technological equipment and therapy methodology is deep-rooted in Ayurvedic treatment methods.
Strength
Affordable treatments
The affordable and non-invasive nature of treatments makes them accessible to all sections of society, enabling even those with meager means to get help for their condition
Strength
Technology driven
The company has an in-house IT platform which has helped increase its efficiency by coming up with innovations
Strength
Vaidya Sane Ayurved Risks
Legal proceedings
There are certain outstanding legal proceeding against the company
Risk
Contingent liabilities
There are certain contingent liabilities that have not been provided for in the financial statements, which, if they materialize, may adversely affect the results of operations, financial condition and cash flows.
Risk
IPO FAQs
The promoter of the company is Rohit Madhav Sane.
The category allocation of qualified institutional buyers is 0.0%, the category allocation of non individual investors or high networth individuals is 50.0% and for retail investors it is 50.0%.
The price band of the IPO is Rs 73.0 - 73.0.
The IPO application opens on Feb 10, 2022 and closes on Feb 15, 2022.
The minimum lot size for the IPO is 1600. The maximum lot size for the IPO is 1600.
For all category investors, the minimum application amount for this IPO is Rs. 116,800.0, the maximum value for this IPO is Rs 116,800.0.
This IPO will be allotted on Feb 18, 2022.
The refund will be credited to your account on Feb 21, 2022.
The allotted shares will be credited to your demat on Feb 22, 2022.
Vaidya Sane Ayurved Laboratories Ltd.’s shares listed on the stock exchanges on Feb 23, 2022.